Abstract | PURPOSE: METHODS: In a preliminary short-term experiment, male mice of three genotypes were given s.c. of 20 mg/kg DMH once weekly for 5 weeks. In a medium-term experiment, mice were given weekly s.c. of DMH for 15 weeks. In a long-term experiment, male p53 (+/-) and (+/+) mice were given weekly injections of DMH for 15 weeks, and killed at week 30. RESULTS: In the medium-term experiment, carcinomas were observed in 70% of p53 (-/-) mice, although there were no carcinomas in p53 (+/+) and (+/-) mice. In the long-term experiment, there was no significant difference in incidences of adenomas and carcinomas between p53 (+/+) and (+/-) mice. PCR-single strand conformation polymorphism analysis of exons 5-8 of p53 gene revealed four mutations in one focal atypia, one adenoma, and two carcinomas, out of 56 colonic proliferative lesions in the medium- and long-term experiments. CONCLUSIONS: These results suggest that p53 might not be a direct target of DMH but complete loss of p53 might elevate susceptibility to DMH-induced colorectal carcinogenesis.
|
Authors | Hiroki Sakai, Tetsuya Tsukamoto, Masami Yamamoto, Norimitsu Shirai, Takeshi Iidaka, Akihiro Hirata, Tokuma Yanai, Toshiaki Masegi, Lawrence A Donehower, Masae Tatematsu |
Journal | Journal of cancer research and clinical oncology
(J Cancer Res Clin Oncol)
Vol. 129
Issue 6
Pg. 335-40
(Jun 2003)
ISSN: 0171-5216 [Print] Germany |
PMID | 12743811
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carcinogens
- 1,2-Dimethylhydrazine
|
Topics |
- 1,2-Dimethylhydrazine
(adverse effects)
- Animals
- Carcinogens
(adverse effects)
- Carcinoma
(chemically induced, genetics, veterinary)
- Cell Transformation, Neoplastic
- Colorectal Neoplasms
(chemically induced, genetics, veterinary)
- Disease Models, Animal
- Genes, p53
(genetics)
- Genotype
- Injections, Subcutaneous
- Male
- Mice
- Mice, Knockout
|